Press release
Japan Multi-Cancer Early Detection Testing Market Expands at 16.5% CAGR as Liquid Biopsy and AI-Driven Genomics Transform Early Cancer Screening
Multi-Cancer Early Detection Testing Market
As per DataM Intelligence research report "The global multi cancer early detection testing market reached US$ 1.67 billion in 2023, with a rise of US$ 1.92 billion in 2024, and is expected to reach US$ 7.52 billion by 2033, growing at a CAGR of 16.5% from 2025 to 2033." Rising global cancer prevalence, demand for non-invasive liquid biopsy technologies, advancements in genomics, AI-driven bioinformatics, next-generation sequencing, and supportive clinical studies are fueling growth in the multi cancer early detection testing market.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/multi-cancer-early-detection-testing-market?sindhuri
Japan: Recent Industry Developments
✅ In 2025, Japanese oncology centers and research institutions advanced adoption of liquid biopsy-based MCED approaches, integrating AI and genomic analysis for high-risk screening in aging populations.
✅ In 2025, Collaborations with global players like Guardant Health expanded access to methylation-based multi-cancer tests, aligning with Japan's focus on precision oncology and early intervention.
✅ In 2025, Government-backed initiatives promoted multi-cancer screening pilots, emphasizing non-invasive solutions amid rising incidence of lung, colorectal, and breast cancers.
United States: Recent Industry Developments
✅ In September 2025, Exact Sciences launched CancerguardTM, a first-of-its-kind multi-cancer early detection blood test analyzing multiple biomarker classes, available as an LDT nationwide through Quest Diagnostics.
✅ In June 2025, Guardant Health received FDA Breakthrough Device designation for its Shield multi-cancer detection test (methylation-based) for average-risk individuals aged 45+.
✅ In July 2025, Fred Hutch Cancer Center launched the Vanguard Study, a national evaluation of multi-cancer detection blood tests for early screening in ages 45-75.
Multi Cancer Early Detection Testing Market: Drivers
The multi cancer early detection testing market is driven by escalating global cancer burden (20 million new cases and 9.7 million deaths annually), limitations of traditional single-cancer screening, and demand for non-invasive, accurate alternatives like liquid biopsies. Technological progress in cfDNA methylation, next-generation sequencing, AI-powered analysis, and multi-biomarker approaches enable detection of multiple cancers from a single blood draw, improving early-stage identification and outcomes. Supportive regulatory designations, clinical validations, real-world evidence studies, and investments in precision oncology further accelerate adoption amid preventive healthcare priorities.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/multi-cancer-early-detection-testing-market?sindhuri
Multi Cancer Early Detection Testing Market: Major Players
GRAIL (Galleri), Guardant Health, Exact Sciences (Cancerguard/CancerSEEK), Burning Rock Biotech, Lucence Health, Foundation Medicine (Roche), AnchorDx, Freenome, Niramai.
Segment Covered in the Multi Cancer Early Detection Testing Market:
By Test Type
Galleri Test (dominant with ~40.66% share), CancerSEEK, Others.
By Cancer Type
Breast Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Others.
By End User
Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes.
Regional Analysis
North America - Dominant Share
North America holds 42.1% market share in 2024, driven by high cancer prevalence, advanced infrastructure, R&D investments, reimbursement support, and presence of leaders like GRAIL, Exact Sciences, and Guardant Health.
Asia Pacific - Fastest-Growing
Asia Pacific expands rapidly due to rising cancer incidence, improving diagnostics, healthcare investments, and adoption of innovative liquid biopsy technologies in emerging economies.
Europe - Significant Share
Europe grows with focus on precision medicine and regulatory support for novel diagnostics.
South America - Gradual Growth
South America shows steady progress amid increasing awareness and healthcare enhancements.
Middle East & Africa - Emerging Growth
Middle East & Africa rises with investments in oncology and growing demand for early detection.
Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=multi-cancer-early-detection-testing-market?sindhuri
(Purchase 2 or more Reports and get 50% Discount)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sindhuri
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Japan Multi-Cancer Early Detection Testing Market Expands at 16.5% CAGR as Liquid Biopsy and AI-Driven Genomics Transform Early Cancer Screening here
News-ID: 4343629 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
United States Non-Invasive Glucose Monitoring Devices Market Grows at 7.5% CAGR …
Leander, Texas and Tokyo, Japan - Jan.12.2026
As per DataM Intelligence research report " global non-invasive glucose monitoring devices market reached US$ 29.53 Million in 2023, with a rise of US$ 31.57 Million in 2024 and is expected to reach US$ 60.71 Million by 2033, growing at a CAGR of 7.5% from 2025 to 2033." Rising global diabetes prevalence, patient preference for pain-free needle-free technologies, advancements in sensor and wearable innovations,…
Japan Mycelium-Based Meat Alternatives Market Expands at 13.20% CAGR as Ultra-Lo …
Leander, Texas and Tokyo, Japan - Jan.12.2026
As per DataM Intelligence research report "Mycelium-Based Meat Alternatives Market reached US$ 971.25 million in 2024 and is expected to reach US$ 2,592.78 million by 2032, growing with a CAGR of 13.20% from 2025 to 2032." Rising consumer demand for sustainable, clean-label, and ultra-low-emission protein sources, technological advancements in fermentation, government support for alternative proteins, and integration into food supply chains are fueling growth…
Femtech Market to Reach US$ 112.30 Billion by 2033, Driven by Rising Awareness o …
The Global Femtech Market reached US$ 38.90 billion in 2024 and is expected to reach US$ 112.30 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.
According to DataM Intelligence has published a new research report on "Femtech Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers.…
United States Petrochemicals Market Expected to Grow at 5.8% CAGR Through 2031, …
Leander, Texas and Tokyo, Japan - Jan.09.2026,As per DataM intelligence research report "Petrochemicals market size is estimated to reach USD million by 2031, growing at a CAGR of 6% during the forecast period 2024-2031." Rising demand for plastics, synthetic fibers, and specialty chemicals, coupled with expanding end-use industries and capacity additions in Asia, continues to drive the petrochemicals sector despite energy transition pressures.
Download your exclusive sample report today: (corporate email…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
